Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Feb;70(820):100–103. doi: 10.1136/pgmj.70.820.100

The effect of different nitrate preparations on plasma heparin concentrations and the activated partial thromboplastin time.

M J Brack 1, R S More 1, P J Hubner 1, A H Gershlick 1
PMCID: PMC2397649  PMID: 8170877

Abstract

There is evidence that intravenous nitrates which are frequently used in acute coronary syndromes may interfere with the anticoagulant effect of heparin. We compared the effect of two different nitrate preparations on the activated partial thromboplastin time (APTT), anti-thrombin III activity (AT III) and plasma heparin levels in patients (n = 50) undergoing routine percutaneous transluminal coronary angioplasty (PTCA) for stable angina. Patients were randomized to either: (1) intravenous heparin and nitroglycerin (GTN); or (2) intravenous heparin and isosorbide dinitrate. The APTT, plasma heparin concentration and AT III activity were measured before PTCA and at 2 and 4 hours after commencement of infusions. Both groups received identical doses of heparin. Group 1 patients received a constant dose of 16.6 micrograms/minute of GTN, and group 2 patients received 33.3 micrograms/minute of isosorbide dinitrate. At 4 hours the median APTT ratio was significantly lower in group 1 compared with group 2 (2.6 versus 4.5) (P < 0.05) as was the plasma heparin concentration (0.18 U/ml versus 0.32 U/ml (P < 0.05). However, no significant difference in APTT ratios or plasma heparin concentrations were noted at any of the other sample times. AT III activity was not significantly different between the groups at any sample time. Within-group analysis showed significantly lower APTT ratio and heparin concentrations at 4 hours compared with the respective 2 hour values. These results would suggest that there is a potential impairment of anticoagulation with low-dose intravenous nitroglycerin and to a lesser extent with low-dose isosorbide dinitrate. Early and frequent monitoring may therefore be appropriate when intravenous nitrates and heparin are used in combination.

Full text

PDF
100

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker R. C., Corrao J. M., Bovill E. G., Gore J. M., Baker S. P., Miller M. L., Lucas F. V., Alpert J. A. Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormality. Am Heart J. 1990 Jun;119(6):1254–1261. doi: 10.1016/s0002-8703(05)80172-3. [DOI] [PubMed] [Google Scholar]
  2. Bode V., Welzel D., Franz G., Polensky U. Absence of drug interaction between heparin and nitroglycerin. Randomized placebo-controlled crossover study. Arch Intern Med. 1990 Oct;150(10):2117–2119. [PubMed] [Google Scholar]
  3. Brack M. J., More R. S., Hubner P. J., Gershlick A. H. The effect of low dose nitroglycerin on plasma heparin concentrations and activated partial thromboplastin times. Blood Coagul Fibrinolysis. 1993 Feb;4(1):183–186. [PubMed] [Google Scholar]
  4. Brack M. J., More R. S., Spring E., Gershlick A. H. Therapeutic levels of nitroglycerin do not affect the uptake and release of heparin by endothelial cells in vitro. Thromb Res. 1993 May 15;70(4):329–335. doi: 10.1016/0049-3848(93)90105-w. [DOI] [PubMed] [Google Scholar]
  5. Col J., Col-Debeys C., Lavenne-Pardonge E., Meert P., Hericks L., Broze M. C., Moriau M. Propylene glycol-induced heparin resistance during nitroglycerin infusion. Am Heart J. 1985 Jul;110(1 Pt 1):171–173. doi: 10.1016/0002-8703(85)90534-4. [DOI] [PubMed] [Google Scholar]
  6. Ellis S. G., Roubin G. S., Wilentz J., Douglas J. S., Jr, King S. B., 3rd Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989 Apr;117(4):777–782. doi: 10.1016/0002-8703(89)90612-1. [DOI] [PubMed] [Google Scholar]
  7. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985 Apr;71(4):699–708. doi: 10.1161/01.cir.71.4.699. [DOI] [PubMed] [Google Scholar]
  8. Habbab M. A., Haft J. I. Heparin resistance induced by intravenous nitroglycerin. A word of caution when both drugs are used concomitantly. Arch Intern Med. 1987 May;147(5):857–860. [PubMed] [Google Scholar]
  9. Habbab M. A., Haft J. I. Intravenous nitroglycerin and heparin resistance. Ann Intern Med. 1986 Aug;105(2):305–305. doi: 10.7326/0003-4819-105-2-305_1. [DOI] [PubMed] [Google Scholar]
  10. Kaplan K., Davison R., Parker M., Przybylek J., Teagarden J. R., Lesch M. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. Am J Cardiol. 1983 Mar 1;51(5):694–698. doi: 10.1016/s0002-9149(83)80117-9. [DOI] [PubMed] [Google Scholar]
  11. Lepor N. E., Amin D. K., Berberian L., Shah P. K. Does nitroglycerin induce heparin resistance? Clin Cardiol. 1989 Aug;12(8):432–434. doi: 10.1002/clc.4960120806. [DOI] [PubMed] [Google Scholar]
  12. Schoenenberger R. A., Ménat L., Weiss P., Marbet G. A., Ritz R. Absence of nitroglycerin-induced heparin resistance in healthy volunteers. Eur Heart J. 1992 Mar;13(3):411–414. doi: 10.1093/oxfordjournals.eurheartj.a060182. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES